Worldwide Clinical Trials Completes Catalyst Clinical Research Acquisition to Expand Oncology and Global CRO Capabilities

CRO expands oncology, adds functional service provider capabilities, strengthens global reach, and accelerates technology to enhance customer value ...

February 18, 2026 | Wednesday | News
Sapu Bioscience Secures Global IP Fortress for OT-101, Advancing Integrated CNS Platform in Neurology and Oncology

Sapu Bioscience announced advancements in its global IP portfolio supporting OT-101, its proprietary TGF-β antisense therapeutic platform, stre...

February 18, 2026 | Wednesday | News
QuidelOrtho Strengthens Global Immunoassay Portfolio Through Strategic Agreement With Lifotronic Technology

QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 68838...

February 17, 2026 | Tuesday | News
Kevin Conroy Emphasizes Strong Momentum as Exact Sciences Corp. Reports 23% Q4 Revenue Growth and Expanding Oncology Portfolio

Total fourth quarter revenue of $878 million, an increase of 23% on a reported and core revenue basis, with Screening revenue of $695 million and Pre...

February 16, 2026 | Monday | Company results
MEDIPOST Inc. Files IND Amendment to Advance Phase III Stem Cell Therapy Trial for Knee Osteoarthritis

MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative disea...

February 16, 2026 | Monday | News
Alto Neuroscience, Inc. Completes Patient Enrollment in Phase 2 Trial of ALTO-101 for Schizophrenia-Related Cognitive Impairment

-Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medi...

February 16, 2026 | Monday | News
Sanofi Appoints Belén Garijo as CEO, Signaling Bold Leadership Shift to Strengthen Innovation and Performance

Belén Garijo to become Chief Executive Officer of Sanofi Sanofi's Board of Directors met on February 11, 2026, and decided not to renew the Direc...

February 13, 2026 | Friday | News
Valar Labs Expands AI Oncology Platform with Vitara Pancreas ChemoPredict Validation

New AI diagnostic, Vitara Pancreas ChemoPredict, can select optimal first-line treatment for advanced pancreatic cancer patients. Valar Labs, ...

February 13, 2026 | Friday | News
Apimeds and Lōkahi Therapeutics Secure FDA Type C Meeting for LT-100 in Osteoarthritis

Apimeds Pharmaceuticals US, Inc. and Lōkahi Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) Division of Anesthesiology, Ad...

February 13, 2026 | Friday | News
Agilent PD L1 IHC 22C3 PharmDx Secures FDA Approval To Guide KEYTRUDA In Ovarian Cancer

Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA® (pembrolizumab)1, 2 Agilent Technologies Inc. announced ...

February 13, 2026 | Friday | News
CEO Daniel O’Day Underscores Strength of Gilead’s HIV Franchise After Solid 2025 Results

  Product Sales Excluding Veklury Increased 4% Year-Over-Year to $28.0 billion for Full Year 2025 Biktarvy Sales Increased 7% Year-Over-Year to $1...

February 12, 2026 | Thursday | Company results
Waters Expands into Global Diagnostics and Biosciences Powerhouse with BD Transaction Close

  Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-...

February 11, 2026 | Wednesday | News
Azenta Partners with Frontier Space to Advance Life Sciences Research in Microgravity

Azenta, Inc.  announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge s...

February 11, 2026 | Wednesday | News
Applied Medical Wins $381 Million Antitrust Verdict Against Medtronic

A team from Knobbe Martens obtained a decisive win for medical device manufacturer Applied Medical against Medtronic, Inc. in an antitrust case involving...

February 11, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close